Sloan Kettering Institute Scientists retool CAR T cells to serve as ‘micropharmacies’ for cancer drugs
Scienmag
DECEMBER 30, 2021
Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. Now, scientists at Memorial Sloan Kettering Cancer Center’s Sloan Kettering Institute (SKI) have developed new CAR T cells that can do something their […].
Let's personalize your content